Clinical characteristics of cutaneous melanoma and second primary malignancies in a Dutch hospital-based cohort of cutaneous melanoma patients

Dermatology Research and Practice

Volumn 2009, Issue 1, 2009, Pages

  Van Der Velden, Haike M J ^a   Van Rossum, Michelle M ^a   Blokx, Willeke A M ^a   Boezeman, Jan B M ^a   Gerritsen, Marie Jeanne P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865568054     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2009/479183     Document Type: Article

References (61)

1. de Vries E., e.devries@erasmusmc.nl van de Poll-Franse L. V., Louwman W. J., de Gruijl F. R., Coebergh J. W. W., Predictions of skin cancer incidence in The Netherlands up to 2015. British Journal of Dermatology 2005 152 3 481 488 2-s2.0-0028908880 10.1111/j.1365-2133.2005.06386.x (Pubitemid 40547122)
2. de Vries E., e.devries@erasmusmc.nl Bray F. I., Coebergh J. W. W., Parkin D. M., Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. International Journal of Cancer 2003 107 1 119 126 2-s2.0-0033753505 10.1002/ijc.11360 (Pubitemid 37100095)
3. Jemal A., Devesa S. S., Hartge P., Tucker M. A., Recent trends in cutaneous melanoma incidence among whites in the United States. Journal of the National Cancer Institute 2001 93 9 678 683 2-s2.0-0035795581 (Pubitemid 32492808)
4. MacKie R. M., Bray C. A., Hole D. J., Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. The Lancet 2002 360 9333 587 591 10.1016/S0140-6736(02)09779-9 2-s2.0-0037167236 (Pubitemid 35232190)
5. Marrett L. D., Nguyen H. L., Armstrong B. K., Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. International Journal of Cancer 2001 92 3 457 462 10.1002/ijc.1203 2-s2.0-0035342504 (Pubitemid 32249726)
6. Levi F., Te V. C., Randimbison L., Erler G., La Vecchia C., Trends in skin cancer incidence in Vaud: an update, 1976-1998. European Journal of Cancer Prevention 2001 10 4 371 373 10.1097/00008469-200108000-00011 2-s2.0-0034897127 (Pubitemid 32735354)
7. Stang A., Stang K., Stegmaier C., Hakulinen T., Jöckel K.-H., Skin melanoma in saarland: incidence, survival and mortality 1970-1996. European Journal of Cancer Prevention 2001 10 5 407 415 10.1097/00008469-200110000-00004 2-s2.0-0034749441 (Pubitemid 33016251)
8. Ocaña-Riola R., Martínez-García C., Serrano S., Buendía-Eisman A., Ruíz-Baena C., Canela-Soler J., Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. European Journal of Epidemiology 2001 17 2 169 174 10.1023/A:1017930504671 2-s2.0-0034805947 (Pubitemid 32900045)
9. Siesling S., Visser O., van Dijck J. A. A. M., Coebergh J. W. W., Trends in the incidence and death from cancer from 1989-2003 in The Netherlands. Nederlands Tijdschrift voor Geneeskunde 2006 150 45 2490 2496 2-s2.0-33751197690
10. Buettner P. G., Leiter U., Eigentler T. K., Garbe C., Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 2005 103 3 616 624 10.1002/cncr.20816 2-s2.0-12744261226
11. Garbe C., McLeod G. R. C., Buettner P. G., Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000 89 6 1269 1278 10.1002/1097-0142(20000915)89:6<269::AID-CNCR11>3.0.CO;2-C 2-s2.0-0034666246
12. Bhatia S., Estrada-Batres L., Maryon T., Bogue M., Chu D., Second primary tumors in patients with cutaneous malignant melanoma. Cancer 1999 86 10 2014 2020 10.1002/(SICI)1097-0142(19991115)86:10<2014::AID-CNCR19>3.0.CO;2-4 2-s2.0-0033571536
13. DiFronzo L. A., Wanek L. A., Elashoff R., Morton D. L., Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Annals of Surgical Oncology 1999 6 7 705 711 2-s2.0-0032700048
14. Levi F., La Vecchia C., Randimbison L., Te V.-C., Erler G., Incidence of invasive cancers following cutaneous malignant melanoma. International Journal of Cancer 1997 72 5 776 779 10.1002/(SICI)1097-0215(19970904)72:5<776::AID- IJC12>3.0.CO;2-7 2-s2.0-0030760338 (Pubitemid 27431519)
15. Nashan D., Kocer B., Schiller M., Luger T., Grabbe S., Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factors. Dermatology 2003 206 2 76 77 10.1159/000068452 2-s2.0-0037272233 (Pubitemid 36205270)
16. Schmid-Wendtner M.-H., Baumert J., Wendtner C.-M., Plewig G., Volkenandt M., Risk of second primary malignancies in patients with cutaneous melanoma. British Journal of Dermatology 2001 145 6 981 985 10.1046/j.1365-2133.2001. 04507.x 2-s2.0-0035724676 (Pubitemid 34204474)
17. Wassberg C., Thorn M., Yuen J., Hakulinen T., Ringborg U., Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ. International Journal of Cancer 1999 83 3 314 317 10.1002/(SICI)1097-0215(19991029)83: 3<314::AID-IJC5>3.0.CO;2-9 2-s2.0-0344418684 (Pubitemid 29455753)
18. Wassberg C., Thorn M., Yuen J., Ringborg U., Hakulinen T., Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. British Journal of Cancer 1996 73 2 255 259 2-s2.0-0030050694 (Pubitemid 26028343)
19. Crocetti E., Carli P., Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. European Journal of Cancer Prevention 2004 13 1 33 37 10.1097/00008469-200402000-00006 2-s2.0-1542357593 (Pubitemid 38328117)
20. Kroumpouzos G., Konstadoulakis M. M., Cabral H., Karakousis C. P., Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma. Dermatologic Surgery 2000 26 6 547 550 10.1046/j.1524-4725.2000.99292. x 2-s2.0-0033917645 (Pubitemid 30421445)
21. Swerdlow A. J., Storm H. H., Sasieni P. D., Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. International Journal of Cancer 1995 61 6 773 779 10.1002/ijc.2910610606 2-s2.0-0029025203
22. Goggins W. B., Finkelstein D. M., Tsao H., Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001 91 4 874 880 10.1002/1097-0142(20010215)91:4<874::AID-CNCR1076>3.0.CO;2-O 2-s2.0-0035864933 (Pubitemid 32173315)
23. McKenna D. B., Stockton D., Brewster D. H., Doherty V. R., Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. British Journal of Cancer 2003 88 1 74 78 10.1038/sj.bjc.6600692 2-s2.0-0037434414 (Pubitemid 36241221)
24. Gutman M., Cnaan A., Inbar M., Are malignant melanoma patients at higher risk for a second cancer? Cancer 1991 68 3 660 665 2-s2.0-0025951591
25. Tihan T., Filippa D. A., Coexistence of renal cell carcinoma and malignant lymphoma: a causal relationship or coincidental occurrence? Cancer 1996 77 11 2325 2331 10.1002/(SICI)1097-0142(19960601)77:11<2325::AID- CNCR22>3.0.CO;2-Y 2-s2.0-0030003925 (Pubitemid 26162427)
26. Travis L. B., Curtis R. E., Storm H., Risk of second malignant neoplasms among long-term survivors of testicular cancer. Journal of the National Cancer Institute 1997 89 19 1429 1439 2-s2.0-0030966297 (Pubitemid 27419206)
27. Greene M. H., Clark W. H. Jr., Tucker M. A., Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. The Lancet 1980 2 8202 1024 2-s2.0-0018932818 (Pubitemid 10025088)
28. International Agency for Research on Cancer, International rules for multiple primary cancers (ICD-0 Third Edition). 2004, http://www.iacr.com.fr/ MPrules-july2004.pdf
29. Breslow A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery 1970 172 5 902 908 2-s2.0-0014884119
30. Clark W. H. Jr., From L., Bernardino E. A., Mihm M. C., The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Research 1969 29 3 705 727 2-s2.0-0014481136
31. Balch C. M., Buzaid A. C., Soong S.-J., Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. Journal of Clinical Oncology 2001 19 16 3635 3648 2-s2.0-0035881074 (Pubitemid 32786276)
32. Balch C. M., Soong S.-J., Gershenwald J. E., Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. Journal of Clinical Oncology 2001 19 16 3622 3634 2-s2.0-0035880957 (Pubitemid 32786275)
33. Katalinic A., Kunze U., Schafer T., Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). British Journal of Dermatology 2003 149 6 1200 1206 10.1111/j.1365-2133.2003.05554.x 2-s2.0-0347356319 (Pubitemid 38058096)
34. Cho E., Rosner B. A., Colditz G. A., Risk factors for melanoma by body for whites. Cancer Epidemiology Biomarkers and Prevention 2005 14 5 1241 1244 10.1158/1055-9965.EPI-04-0632 2-s2.0-18544379469 (Pubitemid 40656474)
35. Elwood J. M., Gallagher R. P., Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. International Journal of Cancer 1998 78 3 276 280 10.1002/(SICI)1097-0215(19981029)78: 3<276::AID-IJC2>3.0.CO;2-S 2-s2.0-0032578715 (Pubitemid 28445360)
36. Clark L. N., Shin D. B., Troxel A. B., Khan S., Sober A. J., Ming M. E., Association between the anatomic distribution of melanoma and sex. Journal of the American Academy of Dermatology 2007 56 5 768 773 10.1016/j.jaad.2006.12.028 2-s2.0-34147134523 (Pubitemid 46561015)
37. Bevona C., Goggins W., Quinn T., Fullerton J., Tsao H., Corona R., Cutaneous melanomas associated with nevi. Archives of Dermatology 2003 139 12 1620 1624 10.1001/archderm.139.12.1620 2-s2.0-0347504782 (Pubitemid 37523082)
38. Cho E., Rosner B. A., Feskanich D., Colditz G. A., Risk factors and individual probabilities of melanoma for whites. Journal of Clinical Oncology 2005 23 12 2669 2675 10.1200/JCO.2005.11.108 2-s2.0-18444408377 (Pubitemid 46179456)
39. Gandini S., Sera F., Cattaruzza M. S., Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. European Journal of Cancer 2005 41 14 2040 2059 10.1016/j.ejca.2005.03.034 2-s2.0-25144506469 (Pubitemid 41337946)
40. Ford D., Bliss J. M., Swerdlow A. J., Risk of cutaneous melanoma associated with a family history of the disease. International Journal of Cancer 1995 62 4 377 381 10.1002/ijc.2910620403 2-s2.0-0029122011
41. Tucker M. A., Fraser M. C., Goldstein A. M., Elder D. E., Guerry D.-P. IV, Organic S. M., Risk of melanoma and other cancers in melanoma-prone families. Journal of Investigative Dermatology 1993 100 3 350S 355S 2-s2.0-0027419856 (Pubitemid 23083198)
42. Markovic S. N., Erickson L. A., Rao R. D., Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clinic Proceedings 2007 82 3 364 380 10.4065/82.3.364 2-s2.0-33847345059 (Pubitemid 46348938)
43. Bergman W., Watson P., de Jong J., Lynch H. T., Fusaro R. M., Systemic cancer and the FAMMM syndrome. British Journal of Cancer 1990 61 6 932 936 2-s2.0-0025284650 (Pubitemid 20197009)
44. Azizi E., Friedman J., Pavlotsky F., Familial cutaneous malignant melanoma and tumors of the nervous system: a hereditary cancer syndrome. Cancer 1995 76 9 1571 1578 10.1002/1097-0142(19951101)76:9<1571::AID- CNCR2820760912>3.0.CO;2-6 2-s2.0-0028889667
45. Borg A., Sandberg T., Nilsson K., High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. Journal of the National Cancer Institute 2000 92 15 1260 1266 2-s2.0-0034596343 (Pubitemid 30627734)
46. Vasen H. F. A., nfdht@xs4all.nl Gruis N. A., Frants R. R., van der Velden P. A., Hille E. T. M., Bergman W., Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). International Journal of Cancer 2000 87 6 809 811 2-s2.0-0024587396 10.1002/1097-0215(20000915)87:6<809::AID- IJC8>3.0.CO;2-U (Pubitemid 30660559)
47. de vostot Nederveen Cappel W. H., Offerhaus G. J. A., van Puijenbroek M., Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden). Clinical Cancer Research 2003 9 10 3598 3605 2-s2.0-0034011564 (Pubitemid 37169223)
48. Goldstein A. M., Fraser M. C., Struewing J. P., Increased risk of pancreatic cancer in melanoma-prone kindreds with p16(INK4) mutations. The New England Journal of Medicine 1995 333 15 970 974 2-s2.0-0029129816 10.1056/NEJM199510123331504
49. Whelan A. J., Bartsch D., Goodfellow P. J., Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. The New England Journal of Medicine 1995 333 15 975 977 10.1056/NEJM199510123331505 2-s2.0-0029102927
50. Skolnick M. H., Cannon-Albright L. A., Genetic predispositions to breast cancer. Cancer 1992 70 supplement 4 1747 1754 2-s2.0-0026612402
51. Menko F. H., Nooy M. A., Vasen H. F. A., Hereditary mutations in the p53 tumor suppressor gene: the significance for clinical practice. National Work Group Hereditary Mamma Carcinoma. Nederlands Tijdschrift voor Geneeskunde 1996 140 26 1347 1350 2-s2.0-0029683186 (Pubitemid 26225730)
52. Wolff J., Wollina U., Second malignancies in melanoma patients in Thuringia. Journal of the European Academy of Dermatology and Venereology 2000 14 6 479 483 10.1046/j.1468-3083.2000.00162.x 2-s2.0-0034426841 (Pubitemid 32899271)
53. Titus-Ernstoff L., Perry A. E., Spencer S. K., Multiple primary melanoma: two-year results from a population-based study. Archives of Dermatology 2006 142 4 433 438 10.1001/archderm.142.4.433 2-s2.0-33646085107 (Pubitemid 43671641)
54. Savoia P., Quaglino P., Verrone A., Bernengo M. G., Multiple primary melanomas: analysis of 49 cases. Melanoma Research 1998 8 4 361 366 10.1097/00008390-199808000-00010 2-s2.0-0031659144 (Pubitemid 28442568)
55. Kang S., Barnhill R. L., Mihm M. C. Jr., Sober A. J., Multiple primary cutaneous melanomas. Cancer 1992 70 7 1911 1916 2-s2.0-0026759611
56. Diepgen T. L., Mahler V., The epidemiology of skin cancer. British Journal of Dermatology 2002 146 supplement 61 1 6 2-s2.0-0036241593
57. de Vries E., Louwman M., Bastiaens M., de Gruijl F., Coebergh J. W., research@ikz.nl Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. Journal of Investigative Dermatology 2004 123 4 634 638 2-s2.0-0028908880 10.1111/j.0022-202X.2004.23306. x (Pubitemid 39281602)
58. Franceschi S., Levi F., Randimbison L., La Vecchia C., Site distribution of different types of skin cancer: new aetiological clues. International Journal of Cancer 1996 67 1 24 28 10.1002/(SICI)1097-0215(19960703)67:1<24::AID- IJC6>3.0.CO;2-1 2-s2.0-0030040065 (Pubitemid 26236064)
59. Rosso S., Zanetti R., Pippione M., Sancho-Garnier H., Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Research 1998 8 6 573 583 2-s2.0-0032432004 (Pubitemid 29046509)
60. Zanetti R., Rosso S., Martinez C., Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. British Journal of Cancer 2006 94 5 743 751 10.1038/sj.bjc.6602982 2-s2.0-33644840579 (Pubitemid 43361909)
61. Kennedy C., Bajdik C. D., Willemze R., de Gruijl F. R., Bouwes Bavinck J. N., The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. Journal of Investigative Dermatology 2003 120 6 1087 1093 10.1046/j.1523-1747.2003.12246.x 2-s2.0-0038129415 (Pubitemid 36702922)